Results 71 to 80 of about 2,856,278 (190)

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra   +5 more
wiley   +1 more source

Stevens-Johnson syndrome: case report

open access: yes, 2013
Stevens-Johnson-ov sindrom je rijetkak i po život opasna akutna alergijska reakcija koja utječe na kožu i sluznicu. Prikazali smo kliničku sliku, vrjednovanje i liječenje 9-godišnje djevojčice sa Stevens-Johnson-ovim sindromom, koji se pojavio nakon ...
Muci, Manisa, Kuneshka, Numila
core  

Endoscopic cyclophotocoagulation in refractory glaucoma after osteo-odonto-keratoprosthesis in Stevens-Johnson syndrome: a case report [PDF]

open access: yes, 2014
To report successful treatment of refractive glaucoma in a patient submitted to osteo-odonto-keratoprosthesis surgery for Stevens-Johnson ...
Bratu, Adriana   +6 more
core   +1 more source

Integrating Pharmacogenomic Testing Within the 4Ms Framework for Management of Behavioral Symptoms in Advanced Vascular Dementia: A Case Study

open access: yesJournal of the American Geriatrics Society, EarlyView.
Pharmacogenomic‐guided managment of behavioral symptoms within the 4Ms framework.
Gianna Franco   +3 more
wiley   +1 more source

Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare life‐threatening mucocutaneous reactions that remain poorly characterized in pediatric populations. Using the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID), the prevalence of SJS/TEN hospitalizations declined from 0.02% in 2016 to 0.009%
Shazli Razi   +5 more
wiley   +1 more source

[Drug-induced Stevens-Johnson syndrome in a patient with AIDS]

open access: yes, 1993
The Stevens-Johnson syndrome is a severe potentially life-threatening form of the erythema multiforme, affecting both skin and mucous membranes. We present a case of a 49-year-old male patient with AIDS who developed a Stevens-Johnson syndrome while ...
Schlienger, R. G.   +4 more
core  

POST OPERATIVE STEVEN JOHNSON TYPE REACTION SECONDARY TO PIPERACILLIN

open access: yesPakistan Armed Forces Medical Journal, 2019
Toxic epidermal necrolysis (TEN) and Stevens–Johnson syndrome (SJS) are lethal cutaneous reactions to medications stirring1–2 per million individuals every year.
Dr. Anam Liaqat   +2 more
doaj   +2 more sources

Interim Update on Reactive Infectious Mucocutaneous Eruption (RIME)

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Reactive infectious mucocutaneous eruption (RIME), a term describing blistering skin and mucosal lesions, is a term coined by a group of Pediatric Dermatology Research Alliance (PeDRA) researchers and first published in 2021. Since that time, the literature has grown with reports of diverse infectious triggers, management strategies, and ...
Michele Ramien   +11 more
wiley   +1 more source

The Stevens-Johnson syndrome: a case report

open access: yes, 2012
Stevens-Johnson syndrome is a serious systemic disorder in which there are fever, vesicobullous lesions involving the skin and mucous membranes. It can result as an immune response to an antigen or as a drug reaction.
Kose, ŞÜKRAN   +2 more
core  

Stevens-Johnson Syndrome Supplementary Tables and Figures

open access: yes, 2023
Supplementary Tables (I-X) and Figures (1-3) for article titled "Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome."THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ...
Wasuwanich, P (via Mendeley Data)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy